Crystallization and polymorphic transition behavior of chloramphenicol palmitate in 2-hydroxypropyl-β-cyclodextrin matrix

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 1, 1997, Pages 23-30

  Hirayama, Fumitoshi ^a   Usami, Megumi ^a   Kimura, Kenya ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

2 Hydroxypropyl cyclodextrin; Chloramphenicol palmitate; Crystallization; Dissolution; Inclusion complexation; Oral bioavailability; Polymorphic transition

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHLORAMPHENICOL PALMITATE;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; COMPLEX FORMATION; CRYSTALLIZATION; DISSOLUTION; DOG; DRUG ABSORPTION; DRUG SOLUBILITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHASE TRANSITION; PRIORITY JOURNAL; STORAGE;

EID: 0031024463     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(96)00250-3     Document Type: Article

References (24)

1. Aguiar, A.J., Krc, Jr. J., Kinkel, A.W. and Samyn, J.C. (1967) Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56, 847-853.
2. Borka, L. (1991) Review on crystal polymorphism of substrates in the European Pharmacopoeia. Pharm. Acta Helv. 66, 16-22.
3. Burger, A. (1977) Neu Untersuchungsergebnisse zur Polymorphie von Chloramphenicolpalmitat. Sci. Pharm. 45, 269-281.
4. Burger, A. and Ramberger, R. (1979) On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules. Mikrochim. Acta 2, 273-316.
5. Duchêne, D. (Ed.) (1987) New Trends in Cyclodextrins and Their Derivatives. Edition de Santé, Paris.
6. Eguchi, Y. and Iitaka, Y. (1974) The β-form of chloramphenicol palmitate. Acta Cryst. B30, 2781-2783.
7. Glazko, A.J., Edgerton, W.H., Dill, W.A. and Lenz, W.R. (1952) Chloromycetin palmitate - a synthetic ester of chloromycetin. Antibiot. Chemother. 2, 234-242.
8. 1H NMR study. J. Incl. Phenom. 17, 149-156.
9. Haleblian, J.K. (1975) Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64, 1269-1288.
10. Higuchi, T. and Connors, K.A. (1965) Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212.
11. Higuchi, T. and Kristiansen, H. (1970) Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies. J. Pharm. Sci. 59, 1601-1608.
12. Hirayama, F., Wang, Z. and Uekama, K. (1994) Effect of 2-hydroxypropyl-β-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state. Pharm. Res. 11, 1766-1770.
13. Junginger, H. (1976) Spray drying polymorphic drugs. Part 3. Spray drying of chloramphenicol palmitate. Pharm. Ztg. 121, 1107-1110.
14. Kaneniwa, N. and Otsuka, M. (1985) Effect of grinding on the transformation of polymorphs of chloramphenicol palmitate. Chem. Pharm. Bull. 33, 1660-1668.
15. Keipert, S. and Hildebrandt, S. (1990) Interaction between macromolecular adjuvants and drugs. Part 28. The effect of starch derivatives on the dissolution characteristics of chloramphenicol. Pharmazie 45, 111-116.
16. Miyamoto, M.A., Kiyotake, T., Kisoh, N.A., Mitsunaga, T. and Maeda, T. (1973) Differential scanning calorimetry of chloramphenicol palmitate and the phase-transition behavior of chloramphenicol palmitate observed during the preparation of its oral preparation. Chem. Pharm. Bull. 21, 1857-1867.
17. Müller, B.W. and Brauns, U. (1985) Solubilization of drugs by modified β-cyclodextrins. Int. J. Pharm. 26, 77-88.
18. Nogami, H., Nagai, T. and Yotsuyanagi, Y. (1969) Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull. 17, 499-509.
19. Nyqvist, H. (1983) Saturated salt solution for maintaining specified relative humidities. Int. J. Pharm. 4, 47-78.
20. Pitha, J. (1988) Amorphous soluble cyclodextrins, pharmaceutical and therapeutic uses. J. Bioact. Compat. Polym. 3, 157-163.
21. Szejtli, J. (1988) Cyclodextrin Technology. Kluwer, Dordrecht.
22. Szulzewsky, K., Kulpe, S., Schulz, B. and F.-Schmittler, H. (1982) Crystallographic results on the polymorphism of chloramphenicol palmitate. Acta Pharm. Suec. 19, 457-470.
23. Uekama, K. and Otagiri, M. (1987) Cyclodextrins in drug carrier systems. CRC Crit. Rev. Ther. Drug Carrier Syst. 3, 1-40.
24. Yoshida, A., Yamamoto, M., Irie, T., Hirayama, F. and Uekama, K. (1989) Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-β-cyclodextrins and their solubilizing and stabilizing abilities. Chem. Pharm. Bull. 37, 1059-1063.